ProShares Short MSCI Emerging MarketsEUM

ProShares’ inverse emerging-markets ETF, ticker EUM , is a daily -1x concentrated bet against the MSCI Emerging Markets Index, meaning it resets every trading day to deliver the inverse of the index’s return. It’s not a buy-and-hold hedge against global slowdowns or a diversified play on emerging-market equities; it’s a one-day trade dressed up in a glossy wrapper. The fund’s mandate is explicit: it tracks the inverse of the MSCI Emerging Markets Index’s daily return, not its monthly or quarterly performance. That distinction matters when the index whipsaws in a single session and the ETF’s synthetic exposure resets to -1x of the new level, amplifying both gains and losses in equal measure.

The issuer’s marketing frames these inverse and concentrated ETFs as tools for ‘strategic and tactical opportunities’ to ‘manage risk and enhance returns,’ language that sounds like it was written by a committee of optimists who’ve never had to explain a 20% drawdown to a retail investor over a pint. The reality is that EUM is a synthetic product built on swaps and futures, designed to deliver the inverse of the index’s daily return. The fund’s expense ratio is a hefty 0.95% per year, which may not sound like much until you consider it compounds daily against a negative return stream. ProShares’ own disclosures warn that imperfections in benchmark correlation, leverage, and market price variance can turn a tidy trade into a messy exit, and the fine print clarifies that these ETFs are ‘generally non-diversified’ and carry risks including the use of derivatives, imperfect benchmark correlation, leverage, and market price variance.

ProShares’ official materials state the company is ‘the leader in strategies such as dividend growth, interest rate hedged bond and geared (concentrated and inverse) ETF investing’ and that it ‘continues to innovate with products that provide strategic and tactical opportunities for investors to manage risk and enhance returns.’ The evidence supplied does not include any recent filings, earnings, or revenue figures specific to EUM, nor does it provide a breakdown of the fund’s top holdings or concentration levels beyond the mandate to track the inverse of the MSCI Emerging Markets Index’s daily return. The fund’s market activity is tracked on Nasdaq, but the evidence does not include any price levels, trading volumes, or asset-under-management figures specific to EUM.

The fund’s tracking method is a daily reset to the inverse of the MSCI Emerging Markets Index, which means its performance is highly sensitive to intraday moves in the underlying index. The issuer’s product pages and risk disclosures do not provide a historical correlation chart or a rolling performance comparison to the index’s daily returns, so investors are left to rely on the fund’s daily reset mechanism and the issuer’s marketing claims. The SEC EDGAR fund search confirms the existence of EUM but does not supply holdings data, expense ratios beyond the 0.95% figure, or AUM figures specific to the fund. The FINRA Fund Analyzer tool is not referenced in the supplied evidence and therefore cannot be used to corroborate expense ratios, performance metrics, or risk factors in this file.

What changed today: the evidence supplied does not include any named news developments, filings, or earnings updates specific to EUM. The fund’s market activity is tracked on Nasdaq, but no price moves, volume spikes, or liquidity events are supplied in the evidence. The issuer’s marketing materials and disclosures remain the primary sources for understanding the fund’s mandate, risks, and tracking method. The fund’s expense ratio is 0.95%, its mandate is a daily -1x bet on the MSCI Emerging Markets Index, and its holdings are synthetic, constructed via swaps and futures, not the actual securities in the index. The evidence does not include AUM figures, top holdings, or concentration levels specific to EUM, nor does it supply a chart route or levels for comparison.